Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 7 studies | 27% ± 11% | |
endothelial cell | 6 studies | 25% ± 9% | |
epithelial cell | 5 studies | 25% ± 7% | |
oligodendrocyte | 5 studies | 20% ± 2% | |
astrocyte | 4 studies | 27% ± 7% | |
glutamatergic neuron | 4 studies | 37% ± 13% | |
GABAergic neuron | 3 studies | 38% ± 2% | |
dendritic cell | 3 studies | 22% ± 2% | |
natural killer cell | 3 studies | 17% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 4680.58 | 459 / 459 | 100% | 30.76 | 1118 / 1118 |
esophagus | 100% | 3482.24 | 1445 / 1445 | 100% | 30.38 | 183 / 183 |
lung | 100% | 3774.30 | 578 / 578 | 100% | 25.39 | 1155 / 1155 |
skin | 100% | 4778.40 | 1809 / 1809 | 100% | 44.50 | 472 / 472 |
intestine | 100% | 3798.54 | 966 / 966 | 100% | 26.38 | 526 / 527 |
uterus | 100% | 5042.27 | 170 / 170 | 100% | 32.70 | 458 / 459 |
ovary | 100% | 5155.11 | 180 / 180 | 100% | 24.88 | 429 / 430 |
stomach | 100% | 2897.28 | 359 / 359 | 100% | 27.25 | 285 / 286 |
bladder | 100% | 3489.57 | 21 / 21 | 100% | 26.49 | 502 / 504 |
thymus | 100% | 3722.63 | 653 / 653 | 100% | 22.02 | 602 / 605 |
brain | 100% | 3517.95 | 2631 / 2642 | 100% | 26.72 | 704 / 705 |
prostate | 100% | 4130.10 | 245 / 245 | 99% | 20.66 | 497 / 502 |
pancreas | 100% | 1904.15 | 327 / 328 | 99% | 21.67 | 176 / 178 |
kidney | 100% | 2931.75 | 89 / 89 | 96% | 18.04 | 868 / 901 |
adrenal gland | 100% | 2927.00 | 258 / 258 | 90% | 12.11 | 208 / 230 |
liver | 100% | 1415.89 | 225 / 226 | 89% | 11.72 | 361 / 406 |
adipose | 100% | 4174.81 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3859.10 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 4162.41 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 32.83 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.65 | 1 / 1 |
muscle | 100% | 2598.81 | 801 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 22.26 | 79 / 80 |
heart | 98% | 1861.45 | 846 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 22.37 | 28 / 29 |
peripheral blood | 89% | 2292.83 | 824 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006281 | Biological process | DNA repair |
GO_0071038 | Biological process | TRAMP-dependent tRNA surveillance pathway |
GO_0071040 | Biological process | nuclear polyadenylation-dependent antisense transcript catabolic process |
GO_0071035 | Biological process | nuclear polyadenylation-dependent rRNA catabolic process |
GO_0006396 | Biological process | RNA processing |
GO_0071051 | Biological process | poly(A)-dependent snoRNA 3'-end processing |
GO_0071044 | Biological process | histone mRNA catabolic process |
GO_0071036 | Biological process | nuclear polyadenylation-dependent snoRNA catabolic process |
GO_0000184 | Biological process | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay |
GO_0006401 | Biological process | RNA catabolic process |
GO_0042274 | Biological process | ribosomal small subunit biogenesis |
GO_1904872 | Biological process | regulation of telomerase RNA localization to Cajal body |
GO_0032211 | Biological process | negative regulation of telomere maintenance via telomerase |
GO_0071034 | Biological process | CUT catabolic process |
GO_0071037 | Biological process | nuclear polyadenylation-dependent snRNA catabolic process |
GO_0071028 | Biological process | nuclear mRNA surveillance |
GO_1905746 | Biological process | positive regulation of mRNA cis splicing, via spliceosome |
GO_0000460 | Biological process | maturation of 5.8S rRNA |
GO_0000956 | Biological process | nuclear-transcribed mRNA catabolic process |
GO_0006364 | Biological process | rRNA processing |
GO_0071039 | Biological process | nuclear polyadenylation-dependent CUT catabolic process |
GO_0000467 | Biological process | exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
GO_0005730 | Cellular component | nucleolus |
GO_0000178 | Cellular component | exosome (RNase complex) |
GO_0016020 | Cellular component | membrane |
GO_0032040 | Cellular component | small-subunit processome |
GO_0000791 | Cellular component | euchromatin |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000177 | Cellular component | cytoplasmic exosome (RNase complex) |
GO_0101019 | Cellular component | nucleolar exosome (RNase complex) |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0000176 | Cellular component | nuclear exosome (RNase complex) |
GO_0005634 | Cellular component | nucleus |
GO_0004532 | Molecular function | RNA exonuclease activity |
GO_0003727 | Molecular function | single-stranded RNA binding |
GO_0000166 | Molecular function | nucleotide binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0003723 | Molecular function | RNA binding |
GO_0070034 | Molecular function | telomerase RNA binding |
GO_0000175 | Molecular function | 3'-5'-RNA exonuclease activity |
GO_0005515 | Molecular function | protein binding |
Gene name | EXOSC10 |
Protein name | Exosome complex component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2) (P100 polymyositis-scleroderma overlap syndrome-associated autoantigen) (Polymyositis/scleroderma autoantigen 100 kDa) (PM/Scl-100) (Polymyositis/scleroderma autoantigen 2) Alternative protein EXOSC10 Exosome component 10 EXOSC10 protein |
Synonyms | PMSCL RRP6 PMSCL2 |
Description | FUNCTION: Catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome . The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. EXOSC10 is required for nucleolar localization of C1D and probably mediates the association of MTREX, C1D and MPHOSPH6 with the RNA exosome involved in the maturation of 5.8S rRNA. Plays a role in the recruitment of replication protein A complex (RPA) and RAD51 to DNA double-strand breaks caused by irradiation, contributing to DNA repair by homologous recombination . Regulates levels of damage-induced RNAs in order to prevent DNA-RNA hybrid formation at DNA double-strand breaks and limit DNA end resection after damage . Plays a role in oocyte development, maturation and survival (By similarity). Required for normal testis development and mitotic division of spermatogonia (By similarity). Plays a role in proper embryo development (By similarity). Required for global protein translation . Required for cell proliferation . Regulates metabolism of C9orf72-derived repeat RNA that can be translated into toxic dipeptide repeat proteins . . |
Accessions | K7EJ37 Q96G78 Q01780 ENST00000460196.1 ENST00000304457.11 [Q01780-2] L8E6Y6 ENST00000376936.9 [Q01780-1] |